Uncategorized

FDA Approves OTC Naloxone Nasal Spray Rextovy to Expand Opioid Overdose Reversal Access

Katie Montenegro Promoted to Associate VP Project Management

FDA Approves First-In-Class OTC Contraceptive!

FDA Approves First-In-Class OTC Naloxone Nasal Spray!

New Staff

Upcoming FDA Advisory Committee Meetings

Application for First OTC Birth Control Pill in the US

PEGUS Research Embraces and Expands WFH Model

RWE Study Conducted by PEGUS Research Published in Contraception

Sterling IRB Features Pegus Research in Whitepaper Article Titled “PPC and Social Media Patient Recruitment: Strategies for Success”